Chem-fig (Bup HCl Chem Fig)
Chemical structure of buprenorphine hydrochloride showing its molecular bonds and chemical groups in a detailed illustration.*
Buprenorphine Tablet
Product Images NDC 0904-7154
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 0904-7154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ifu-image (Ifu Image)
An illustration showing a person placing a sublingual tablet under their tongue, demonstrating the proper administration method for sublingual tablets such as Buprenorphine.*
Image 01
Label for Major Pharmaceuticals Buprenorphine Sublingual Tablets 2 mg, unit dose packaging containing 30 tablets. The label includes dosage strength, dispensing instructions, storage conditions, safety warnings, manufacturer information, and NDC 0904-7154-04.*
Image 02
Label for Major Pharmaceuticals Buprenorphine Sublingual Tablets, 8 mg strength, unit dose packaging containing 30 tablets. The label prominently displays the product name, dosage form, strength, and instructions to dispense with a medication guide. It includes NDC 0904-7155-04 and usage/storage directions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
